Chopas James George 4

Accession 0001492422-26-000044

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:18 PM ET

Size

4.5 KB

Accession

0001492422-26-000044

Research Summary

AI-generated summary of this filing

Updated Jan 21, 2026

Apellis (APLS) VP/Chief Accounting Officer James Chopas Sells 726 Shares

What Happened James George Chopas, VP and Chief Accounting Officer of Apellis Pharmaceuticals (APLS), disposed of 726 shares in an open-market sale on January 20, 2026. The shares were sold at $19.79 each for total proceeds of $14,370. This was a sale to satisfy tax withholding obligations on recently released restricted stock units, an administrative (not necessarily sentiment-driven) transaction.

Key Details

Transaction date and price: 2026-01-20 — 726 shares sold at $19.79 per share.
Total proceeds: $14,370.
Shares owned after transaction: Not disclosed on this Form 4.
Footnote: F1 — "This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2026."
Filing date and timeliness: Form filed 2026-01-21 for a 2026-01-20 transaction; appears to be filed timely.

Context This sale was recorded as tax-withholding related to RSU vesting (code F), a routine administrative action that does not necessarily indicate the insider's view on the company's outlook.